News Home

How Does Invo Bioscience Inc (INVO) Stock Rank on Wall Street Wednesday?

Wednesday, May 18, 2022 01:44 PM | InvestorsObserver Analysts
How Does Invo Bioscience Inc (INVO) Stock Rank on Wall Street Wednesday?

Wall Street is positive on Invo Bioscience Inc (INVO). On average, analysts give the stock a Buy rating. The average price target is $4.5, which means analysts expect the stock to rise by 278.15% over the next twelve months. That average ranking earns the stock an Analyst Rating of 30, which is better than 30% of stocks based on data compiled by InvestorsObserver.

Overall Score - 4
Wall Street analysts are rating INVO a Buy today. Find out what this means to you and get the rest of the rankings on INVO!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Invo Bioscience Inc Stock Today?

Invo Bioscience Inc (INVO) stock is trading at $1.19 as of 1:36 PM on Wednesday, May 18, a loss of -$0.35, or -22.93% from the previous closing price of $1.55. The stock has traded between $1.19 and $1.65 so far today. Volume today is more active than usual. So far 102,081 shares have traded compared to average volume of 34,291 shares. Click Here to get the full Stock Report for Invo Bioscience Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App